Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hans-Peter Brunner-La Rocca"'
Autor:
Pauline B. C. Linssen, Hans-Peter Brunner-La Rocca, Casper G. Schalkwijk, Joline W. J. Beulens, Petra J. M. Elders, Amber A. van der Heijden, Roderick C. Slieker, Coen D. A. Stehouwer, Ronald M. A. Henry
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 14, p 4944 (2020)
Extracellular matrix protein turnover may play an important role in left atrial (LA) remodelling. The aim is to investigate the associations between matrix metalloproteinase (MMPs), tissue inhibitor of metalloproteinase (TIMP-1) and LA volume index (
Externí odkaz:
https://doaj.org/article/7b81ef064d214db4b597d81d91463c1d
Autor:
Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
OBJECTIVES This study sought to further understand the mechanisms underlying effect of spironolactone and assessed its impact on multiple plasma protein biomarkers and their respective underlying biologic pathways.BACKGROUND In addition to their bene
Autor:
Joseph J Cuthbert, Pierpaolo Pellicori, Johannes Petutschnigg, Franco Cosmi, Blerim Mujaj, João Pedro Ferreira, Fozia Z Ahmed, Nicolas Girerd, Faiez Zannad, Roberto Latini, Timothy Collier, Patrick Rossignol, Beatrice Mariottoni, Jan A. Staessen, John G.F. Cleland, Stephane Heymans, Andrew L. Clark, Job A J Verdonschot, Arantxa González, Hans-Peter Brunner-La Rocca
Publikováno v:
European journal of heart failure, 22(9), 1711-1723. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
International audience; AIMS:Asymptomatic patients with coronary artery disease (CAD), hypertension and/or type 2 diabetes mellitus (T2DM) are at greater risk of developing heart failure (HF). Fibrosis, leading to myocardial and vascular dysfunction,
Autor:
Pierpaolo Pellicori, Patrick Rossignol, Hans-Peter Brunner-La Rocca, Faiez Zannad, John G.F. Cleland, Nicolas Girerd, João Pedro Ferreira
Publikováno v:
Archives of Cardiovascular Diseases
Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2021, 114 (12), pp.814-817. ⟨10.1016/j.acvd.2021.10.003⟩
Archives of Cardiovascular Diseases, 114(12), 814-817. Elsevier Masson
Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2021, 114 (12), pp.814-817. ⟨10.1016/j.acvd.2021.10.003⟩
Archives of Cardiovascular Diseases, 114(12), 814-817. Elsevier Masson
International audience
Autor:
Gerard C.M. Linssen, Paul H M Westendorp, Frank J J Smeele, Philip C. Rademaker, Jasper J. Brugts, Hans-Peter Brunner-La Rocca, Annemarie A. van Drimmelen, Henk-Jan Schaafsma, Check-Hf Investigators, Hendrik J. van de Kamp, Arno W. Hoes
Publikováno v:
JACC: Heart Failure. 7:13-21
Objectives This study investigated adherence to drug therapy guidelines in heart failure (HF) with reduced left-ventricular ejection fraction (LVEF) of Background Despite previous surveys of HF, important uncertainties remain regarding guideline adhe
Autor:
Lutgarde Thijs, Beatrice Mariottoni, Johannes Petutschnigg, Andrew L. Clark, Mamas A. Mamas, Patrick Rossignol, Frank Edelmann, Pierpaolo Pellicori, Timothy Collier, Franco Cosmi, Fozia Z Ahmed, Arantxa González, João Pedro Ferreira, Blerim Mujaj, Mark R. Hazebroek, Joe Cuthbert, Philippe Rouet, Stephane Heymans, Hans-Peter Brunner-La Rocca, Nicolas Girerd, Job A J Verdonschot, Jan A. Staessen, John G.F. Cleland, Faiez Zannad
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. Oxford University Press
European Heart Journal-Cardiovascular Pharmacotherapy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. Oxford University Press
Aims Uncontrolled blood pressure (BP) increases the risk of developing heart failure (HF). The effect of spironolactone on BP of patients at risk of developing HF is yet to be determined. To evaluate the effect of spironolactone on the BP of patients
Autor:
Bela Merkely, Nikolaus Marx, Subodh Verma, Michele Senni, Eduardo Chuquiure-Valenzuela, James L. Januzzi, Vijay K. Chopra, Dong-Ju Choi, Stefan D. Anker, Stefano Taddei, Ileana L. Piña, Juan Esteban Gomez-Mesa, Jose R Gonzalez-Juanatey, Dragos Vinereanu, Sergio V. Perrone, Faiez Zannad, Jian Zhang, Carolyn Su Ping Lam, Stuart J. Pocock, Stefan Janssens, Iain Squire, Waheed Jamal, Hans-Peter Brunner-La Rocca, Peter E. Carson, Javed Butler, David K.L. Sim, EMPEROR-Preserved Trial Investigators, Stephen J. Nicholls, Hiroyuki Tsutsui, Janet Schnee, Martina Brueckmann, João Pedro Ferreira, Piotr Ponikowski, Naveed Sattar, Gerasimos Filippatos, Sven Schnaidt, Edimar Bocchi, Michael Böhm, Jindrich Spinar, Cordula Zeller, Nadia Giannetti, Milton Packer
Publikováno v:
The New England Journal of Medicine, 385, 16, pp. 1451-1461
New England Journal of Medicine, 385(16), 1451-1461. MASSACHUSETTS MEDICAL SOCIETY
N. Engl. J. Med. 385, 1451-1461 (2021)
The New England Journal of Medicine, 385, 1451-1461
New England Journal of Medicine, 385(16), 1451-1461. MASSACHUSETTS MEDICAL SOCIETY
N. Engl. J. Med. 385, 1451-1461 (2021)
The New England Journal of Medicine, 385, 1451-1461
Item does not contain fulltext BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef0d16771035c4e1ad15d0feed20fd3
http://hdl.handle.net/10281/373399
http://hdl.handle.net/10281/373399
Autor:
Vanessa P. M. van Empel, Ping Wang, Anne G. Raafs, Stephane Heymans, Christian Knackstedt, Job Verdonschot, Mark R. Hazebroek, Michiel T H M Henkens, Myrurgia Abdul Hamid, Arantxa González, Javier Díez, Sebastiaan C.A.M. Bekkers, Han G. Brunner, Hans-Peter Brunner-La Rocca, Bouke P Adriaans, Kasper Derks
Publikováno v:
European Journal of Heart Failure, 23, 933-944
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
European Journal of Heart Failure, 23, 6, pp. 933-944
European Journal of Heart Failure
European journal of heart failure, 23(6), 933-944. Wiley
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
European Journal of Heart Failure, 23, 6, pp. 933-944
European Journal of Heart Failure
European journal of heart failure, 23(6), 933-944. Wiley
Aims To determine the prognostic value of multilevel assessment of fibrosis in dilated cardiomyopathy (DCM) patients. Methods and results We quantified fibrosis in 209 DCM patients at three levels: (i) non‐invasive late gadolinium enhancement (LGE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c40944a15fdc72ca9a4b9fc6711a96ce
http://hdl.handle.net/2066/237914
http://hdl.handle.net/2066/237914
Autor:
Christian Zaugg, Sandra Sanders-van Wijk, Nasser Davarzani, Micha T. Maeder, Joël Karel, Dirk Block, Matthias Pfisterer, Evgueni Smirnov, Peter Rickenbacher, Ralf Peeters, Hans-Peter Brunner-La Rocca, Thomas M. Suter, Vinzent Rolny, Rudolf A. de Boer
Publikováno v:
The EPMA Journal, 9(2), 161-173. Springer
Epma journal, 9(2), 161-173. Springer International Publishing AG
The EPMA Journal
Epma journal, 9(2), 161-173. Springer International Publishing AG
The EPMA Journal
Background It is uncertain whether repeated measurements of a multi-target biomarker panel may help to personalize medical heart failure (HF) therapy to improve outcome in chronic HF. Methods This analysis included 499 patients from the Trial of Inte
Autor:
Beat A. Kaufmann, Otmar Pfister, Micha T. Maeder, Time-Chf Investigators, Alain Bernheim, Hans-Peter Brunner-La Rocca, Kaatje Goetschalckx, Peter Rickenbacher, Matthias Pfisterer
Publikováno v:
European Journal of Heart Failure. 19:1586-1596
Aims While the conditions of heart failure (HF) with reduced (HFrEF, LVEF < 40%) and preserved (HFpEF, LVEF ≥ 50%) left ventricular ejection fraction (LVEF) are well characterized, it is unknown whether patients with HF and mid-range LVEF (HFmrEF,